# DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer

> **NCT02079363** · — · UNKNOWN · sponsor: **Aalborg University Hospital** · enrollment: 330 (estimated)

## Conditions studied

- Pancreatic Diseases
- Pancreatic Neoplasms
- Pancreatitis

## Interventions

- **OTHER:** No interventions, this is an observational study

## Key facts

- **NCT ID:** NCT02079363
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2017-08
- **Final completion:** 2018-01
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2014-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02079363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02079363, "DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02079363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*